These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 36378354)

  • 21. Clinical Characteristics and Antifungal Susceptibility of Candida nivariensis from Vulvovaginal Candidiasis.
    Shi Y; Zhu Y; Fan S; Vitagliano A; Liu X; Liao Y; Liang Y; Vitale SG
    Gynecol Obstet Invest; 2020; 85(1):88-93. PubMed ID: 31694024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae.
    Hashemi SE; Shokohi T; Abastabar M; Aslani N; Ghadamzadeh M; Haghani I
    Curr Med Mycol; 2019; 5(4):26-34. PubMed ID: 32104741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
    Mohammadi F; Charkhchian M; Mirzadeh M
    BMC Oral Health; 2023 May; 23(1):261. PubMed ID: 37143002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.
    Dunaiski CM; Kock MM; Chan WY; Ismail A; Peters RPH
    Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38308518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MALDI-TOF mass spectrometry identification and antifungal susceptibility testing of yeasts causing vulvovaginal candidiasis (VVC) in Tebessa (Northeastern Algeria).
    Benhadj M; Menasria T; Ranque S
    Ann Biol Clin (Paris); 2024 Feb; 81(6):576-584. PubMed ID: 38189374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs].
    Fan LY; Liu ZH; Bai XN; Zong X
    Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287
    [No Abstract]   [Full Text] [Related]  

  • 30. Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis.
    Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
    Diagn Microbiol Infect Dis; 2024 May; 109(1):116242. PubMed ID: 38452558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
    Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
    BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    Bitew A; Abebaw Y
    BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
    Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
    Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
    BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
    Mushi MF; Olum R; Bongomin F
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China.
    Yan L; Wang XD; Seyedmousavi S; Yuan JN; Abulize P; Pan WH; Yu N; Yang YL; Hu HQ; Liao WQ; Deng SW
    Mycopathologia; 2019 Jun; 184(3):413-422. PubMed ID: 30968320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
    Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.